Anecortave acetate (15 milligrams) versus photodynamic therapy for treatment of subfoveal neovascularization in age-related macular degeneration. [electronic resource]
Producer: 20060110Description: 3-13 p. digitalISSN:- 1549-4713
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- administration & dosage
- Choroidal Neovascularization -- drug therapy
- Connective Tissue -- drug effects
- Double-Blind Method
- Female
- Fluorescein Angiography
- Fovea Centralis
- Humans
- Macular Degeneration -- complications
- Male
- Middle Aged
- Photochemotherapy
- Photosensitizing Agents -- adverse effects
- Porphyrins -- adverse effects
- Pregnadienediols -- administration & dosage
- Prospective Studies
- Treatment Outcome
- Verteporfin
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.